Short application. If client is within the build charts and can answer "no" to health questions, qualification is probable
Rates
Male/Female, Tobacco/Non-tobacco
Min/Max Issue
$5000-$50,000
Benefit
Pays 100% of benefit for first-ever diagnosis:
Invasive Cancer
Heart Attack
Stroke
Major Organ Transplant
End-stage Renal Disease
Advanced Alzheimer's Disease
Major Burns
Paralysis
Coma
Pays 25% of benefit for first-ever diagnosis/procedure: Coronary Bypass Surgery Cancer in situ (non-invasive)
Pays 10% of benefit for first-ever procedure: Angioplasty
Renewability
Guaranteed to age 75
Benefit Use Restrictions
NONE!
Policy Termination
Upon payment of the full benefit*
Survival Period Requirements
None. Beneficiaries receive benefit if insured meets disease definitions and dies of the first ever diagnosis of a covered disease or procedure
Waiting Period
Coverage begins immediately for all conditions or procedures except for invasive cancer in situ which have a reduced benefit for the first 90 days of the policy.* On the 91st day, cancers receive full benefit amounts (100% of invasive, 25% for non-invasive cancer in situ)
Return of Premium Death Benefit
If insured dies (of any cause), 100% of the premiums paid by the policy owner (less any benefits received) are paid to he the beneficiary)
Riders Available
Return of Premium Rider - 100% of premiums paid (less any benefits received) are returned when policy expires at age 75. If terminated before then, a percentage of premiums paid (less any benefits received) are returned (see table in rider contract) Disability Waiver of Premium Rider - premiums are waived during any period of total disability of the insured. Accidental Death Benefit Spouse Rider Children's Rider
*There is an exception for cancer. If cancer is diagnosed during the first 90 days of the policy, the policy pays 10% of the maximum benefit for invasive cancer or 2.5% of the maximum benefit for cancer in situ (non-invasive). The policy terminates with this payment. If cancer is diagnosed on the 91st + day(s) of the policy, the policy pays 100% of the face amount for invasive cancer or 25% of the face amount for cancer in situ (non-invasive)
Diane